HIRH IN GASTROINTESTINAL MALIGNANCIES
胃肠道恶性肿瘤中的 HIRH
基本信息
- 批准号:2608140
- 负责人:
- 金额:$ 10.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-12-16 至 2001-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Cytokines include interferons, interleukins, growth factors and other
molecules involved in signalling between cells. They play important
stimulatory or inhibitory roles in a wide range of normal and pathologic
processes such as growth regulation, inflammation, repair, viral and
malignant diseases.
The long-term objective of this research proposal is to define the role
in tumor formation, spread or treatment of a new human cytokine, which
we call hIRH, in selected gastrointestinal tissues and malignancies.
Subtractive hybridization techniques to compare differences in gene
expression at the cDNA level have been used to isolate potentially
important genes in malignancy, such as the metastasis suppressor gene
nm23. For a more rapid determination of differential gene expression at
the cDNA level the technique of differential display has detected new
genes, or suggested new roles for known genes in selected malignancies,
e.g. maspin and integrins in breast cancer, PTI-1 in prostate cancer. We
have isolated, by differential display, a range of new and known genes
which we have determined to be differentially expressed in several
gastrointestinal malignancies. This proposal focuses on one such gene,
hIRH, isolated from differential displays of hepatocellular carcinoma and
adjacent non-neoplastic liver, and continues studies to define its
potential role in selected gastrointestinal malignancies.
The specific aims are to define 1) the genetic structure, and 2) the
possible functional role in hepatocellular carcinoma and other tissues,
of hIRH which we have determined to be almost uniformly lost from
hepatocellular carcinomas, in comparison with the adjacent non-neoplastic
livers. Similar cytokines are important either directly, or indirectly
via the induction of an inflammatory response, in the inhibition of tumor
growth. We plan to assess the activity of hIRH on leukocyte chemotaxis
and in growth inhibition, both highly significant processes in tumor
biology.
细胞因子包括干扰素、白细胞介素、生长因子等
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GRAHAM F BARNARD其他文献
GRAHAM F BARNARD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GRAHAM F BARNARD', 18)}}的其他基金
MOLECULAR ASPECTS OF GASTROINTESTINAL MALIGNANCY
胃肠道恶性肿瘤的分子方面
- 批准号:
3034428 - 财政年份:1991
- 资助金额:
$ 10.74万 - 项目类别:
MOLECULAR ASPECTS OF GASTROINTESTINAL MALIGNANCY
胃肠道恶性肿瘤的分子方面
- 批准号:
3034427 - 财政年份:1990
- 资助金额:
$ 10.74万 - 项目类别:
相似海外基金
The development of a novel hydrogel for preventing complications after endoscopic treatment for gastrointestinal neoplasms
开发一种新型水凝胶,用于预防胃肠道肿瘤内镜治疗后的并发症
- 批准号:
21K12680 - 财政年份:2021
- 资助金额:
$ 10.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




